Sun Pharma Advanced Research Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Sun Pharma Advanced Research.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 18.2% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Sun Pharma Advanced Research (NSE:SPARC) Is In A Good Position To Deliver On Growth Plans
Jan 17
Sun Pharma Advanced Research Company Limited's (NSE:SPARC) Business Is Trailing The Industry But Its Shares Aren't
Nov 14Is Sun Pharma Advanced Research (NSE:SPARC) Using Too Much Debt?
Sep 05Here's Why We're Not At All Concerned With Sun Pharma Advanced Research's (NSE:SPARC) Cash Burn Situation
Jun 27Is Sun Pharma Advanced Research (NSE:SPARC) A Risky Investment?
Nov 23If You Had Bought Sun Pharma Advanced Research's (NSE:SPARC) Shares Three Years Ago You Would Be Down 57%
Feb 08
Do Institutions Own Sun Pharma Advanced Research Company Limited (NSE:SPARC) Shares?
Dec 14In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sun Pharma Advanced Research has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | 684 | -3,878 | N/A | N/A | N/A |
| 3/31/2024 | 755 | -3,872 | -4,557 | -4,292 | N/A |
| 12/31/2023 | 1,067 | -3,634 | N/A | N/A | N/A |
| 9/30/2023 | 2,239 | -2,536 | -1,712 | -1,589 | N/A |
| 6/30/2023 | 2,343 | -2,356 | N/A | N/A | N/A |
| 3/31/2023 | 2,388 | -2,226 | -845 | -691 | N/A |
| 12/31/2022 | 2,163 | -2,116 | N/A | N/A | N/A |
| 9/30/2022 | 1,474 | -2,376 | -2,148 | -1,799 | N/A |
| 6/30/2022 | 1,437 | -2,244 | N/A | N/A | N/A |
| 3/31/2022 | 1,372 | -2,034 | -2,409 | -2,082 | N/A |
| 12/31/2021 | 1,401 | -1,891 | N/A | N/A | N/A |
| 9/30/2021 | 997 | -2,408 | -2,766 | -2,677 | N/A |
| 6/30/2021 | 895 | -2,692 | N/A | N/A | N/A |
| 3/31/2021 | 2,530 | -1,511 | -1,579 | -1,519 | N/A |
| 12/31/2020 | 2,476 | -1,940 | N/A | N/A | N/A |
| 9/30/2020 | 2,454 | -1,819 | -1,243 | -812 | N/A |
| 6/30/2020 | 2,450 | -1,615 | N/A | N/A | N/A |
| 3/31/2020 | 768 | -3,124 | -2,648 | -2,108 | N/A |
| 12/31/2019 | 1,389 | -2,222 | N/A | N/A | N/A |
| 9/30/2019 | 1,392 | -2,357 | -2,528 | -2,289 | N/A |
| 6/30/2019 | 1,834 | -1,751 | N/A | N/A | N/A |
| 3/31/2019 | 1,829 | -1,454 | -1,849 | -1,719 | N/A |
| 12/31/2018 | 1,181 | -1,336 | N/A | N/A | N/A |
| 9/30/2018 | 1,177 | -1,226 | N/A | N/A | N/A |
| 6/30/2018 | 717 | -1,826 | N/A | N/A | N/A |
| 3/31/2018 | 783 | -1,970 | N/A | -1,828 | N/A |
| 12/31/2017 | 998 | -2,326 | N/A | N/A | N/A |
| 9/30/2017 | 1,034 | -2,405 | N/A | N/A | N/A |
| 6/30/2017 | 1,829 | -1,630 | N/A | N/A | N/A |
| 3/31/2017 | 1,810 | -1,190 | N/A | -1,280 | N/A |
| 12/31/2016 | 1,827 | -976 | N/A | N/A | N/A |
| 9/30/2016 | 1,932 | -723 | N/A | N/A | N/A |
| 6/30/2016 | 1,415 | -1,048 | N/A | N/A | N/A |
| 3/31/2016 | 1,613 | -700 | N/A | -442 | N/A |
| 12/31/2015 | 1,628 | -698 | N/A | N/A | N/A |
| 9/30/2015 | 1,605 | -477 | N/A | N/A | N/A |
| 6/30/2015 | 1,633 | -314 | N/A | N/A | N/A |
| 3/31/2015 | 1,557 | -395 | N/A | -412 | N/A |
| 12/31/2014 | 1,556 | -326 | N/A | N/A | N/A |
| 9/30/2014 | 1,873 | 173 | N/A | N/A | N/A |
| 6/30/2014 | 1,672 | 111 | N/A | N/A | N/A |
| 3/31/2014 | 1,670 | 303 | N/A | 369 | N/A |
| 12/31/2013 | 1,963 | 769 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if SPARC's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if SPARC's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if SPARC's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if SPARC's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if SPARC's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SPARC's Return on Equity is forecast to be high in 3 years time